D espite substantial investments across research, policy, and legislation, inequities in child health persist and represent a formidable challenge to improving health outcomes for children. Disparities have been demonstrated in numerous health-care settings and across a vast number of chronic conditions (1-4). Root causes of disparities are complex and frequently intertwine multilevel factors such as race/ethnicity, socioeconomic status, discrimination, psychosocial stress, education, economic opportunity, and neighborhood environment (5,6). Although studies documenting disparities in child health have been plentiful, evidencebased interventions and policy solutions to address inequities are still in their infancy. In this issue, Gkourogianni et al. (7) report on disparities in disease severity and outcomes among Hispanic and African-American children with Pediatric Cushing Disease (CD). The authors document disproportionately higher severity of CD in Hispanic and African-American children relative to white children both preoperatively and postoperatively. Both racial/ethnic minority groups also had higher proportions of diagnosis at an advanced stage. The authors postulate a number of mechanisms by which these disparities in CD severity scores occurred. They appropriately highlight variables at the level of the patient (e.g., genetics, social determinants of health), provider (e.g., fund of knowledge, quality of care), and health-care system (e.g., delays in referral, access to subspecialty care). Also important, the authors identify challenges in the conduct of research with respect to minorities being under-represented in pediatric oncology research protocols and clinical trials for rare diseases. Randomized controlled trials (RCTs) are considered the gold standard in determining the effectiveness of health-care interventions (8). However, the reliability of results can be compromised with differential enrollment or retention among subsets of participants (9,10). This disparity constitutes a major obstacle in establishing the effectiveness of treatment modalities in diverse pediatric populations. The aim of this commentary is to review the literature on pediatric disparities in recruitment and retention, and to identify policies and evidence-based strategies with the potential to improve minority participation and completion in clinical trials.